Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean X Luo

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
The American Journal of Drug and Alcohol Abuse|January 26, 2018
Exploring longitudinal course and treatment-baseline severity interactions in secondary outcomes of smoking cessation treatment in individuals with attention-deficit hyperactivity disorderSean X Luo, Melanie Wall, Lirio Covey, et al.
Journal of Translational Internal Medicine|March 2, 2023
Characteristics of the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.2 Subvariant in Jilin, China from March to May 2022Han Liu, Shuai Wang, Siqi Yang, et al.
The American Journal on Addictions|July 5, 2021
Open-label trial of a single-day induction onto buprenorphine extended-release injection for users of heroin and fentanylJohn J Mariani, Amy L Mahony, Samuel C Podell, et al.
World Neurosurgery|October 10, 2017
Identification of Driver Genes and Key Pathways of Glioblastoma Shows JNJ-7706621 as a Novel Antiglioblastoma DrugSheng Zhong, Bo Wu, Xuechao Dong, et al.
Frontiers in Bioengineering and Biotechnology|February 6, 2023
Treatment of abdominal aortic pseudoaneurysm caused by brucellosis with endovascular aneurysm repairXiao Li, Qilong Wang, Yang Zhang, et al.
The American Journal of Psychiatry|March 9, 2023
Risk of Experiencing an Overdose Event for Patients Undergoing Treatment With Medication for Opioid Use DisorderLaura Brandt, Mei-Chen Hu, Ying Liu, et al.
Addiction (Abingdon, England)|December 19, 2020
Explaining differential effects of medication for opioid use disorder using a novel approach incorporating mediating variablesKara E Rudolph, Iván Díaz, Nima S Hejazi, et al.
Drug and Alcohol Dependence Reports|January 16, 2023
Specific polysubstance use patterns predict relapse among patients entering opioid use disorder treatmentYue Pan, Daniel J Feaster, Gabriel Odom, et al.
The American Journal of Drug and Alcohol Abuse|June 7, 2021
An open-label pilot study of pregabalin pharmacotherapy for alcohol use disorderJohn J Mariani, Martina Pavlicova, C Jean Choi, et al.
Drug and Alcohol Dependence|August 21, 2023
Risks of returning to opioid use at treatment entry and early in opioid use disorder treatment: Role of non-opioid substancesFelipe Castillo, Mei-Chen Hu, Ying Liu, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
The American Journal of Drug and Alcohol Abuse|January 26, 2018
Exploring longitudinal course and treatment-baseline severity interactions in secondary outcomes of smoking cessation treatment in individuals with attention-deficit hyperactivity disorderSean X Luo, Melanie Wall, Lirio Covey, et al.
Journal of Translational Internal Medicine|March 2, 2023
Characteristics of the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.2 Subvariant in Jilin, China from March to May 2022Han Liu, Shuai Wang, Siqi Yang, et al.
The American Journal on Addictions|July 5, 2021
Open-label trial of a single-day induction onto buprenorphine extended-release injection for users of heroin and fentanylJohn J Mariani, Amy L Mahony, Samuel C Podell, et al.
World Neurosurgery|October 10, 2017
Identification of Driver Genes and Key Pathways of Glioblastoma Shows JNJ-7706621 as a Novel Antiglioblastoma DrugSheng Zhong, Bo Wu, Xuechao Dong, et al.
Frontiers in Bioengineering and Biotechnology|February 6, 2023
Treatment of abdominal aortic pseudoaneurysm caused by brucellosis with endovascular aneurysm repairXiao Li, Qilong Wang, Yang Zhang, et al.
The American Journal of Psychiatry|March 9, 2023
Risk of Experiencing an Overdose Event for Patients Undergoing Treatment With Medication for Opioid Use DisorderLaura Brandt, Mei-Chen Hu, Ying Liu, et al.
Addiction (Abingdon, England)|December 19, 2020
Explaining differential effects of medication for opioid use disorder using a novel approach incorporating mediating variablesKara E Rudolph, Iván Díaz, Nima S Hejazi, et al.
Drug and Alcohol Dependence Reports|January 16, 2023
Specific polysubstance use patterns predict relapse among patients entering opioid use disorder treatmentYue Pan, Daniel J Feaster, Gabriel Odom, et al.
The American Journal of Drug and Alcohol Abuse|June 7, 2021
An open-label pilot study of pregabalin pharmacotherapy for alcohol use disorderJohn J Mariani, Martina Pavlicova, C Jean Choi, et al.
Drug and Alcohol Dependence|August 21, 2023
Risks of returning to opioid use at treatment entry and early in opioid use disorder treatment: Role of non-opioid substancesFelipe Castillo, Mei-Chen Hu, Ying Liu, et al.
Pageof 5